|
Gene Therapy
Citations 1-10 of 432 total displayed.
|
Most recent content
(12 Nov 2009):
|
Anti-CD3 antibodies modulate anti–factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy
- Baowei Peng, Peiqing Ye, David J. Rawlings, Hans D. Ochs, and Carol H. Miao
Blood 2009; 114: 4373-4382.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Aug 1998):
|
CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII–specific immune responses in plasmid-mediated gene therapy–treated hemophilia mice
- Carol H. Miao, Benjamin R. Harmeling, Steven F. Ziegler, Benjamin C. Yen, Troy Torgerson, Liping Chen, Roger J. Yau, Baowei Peng, Arthur R. Thompson, Hans D. Ochs, and David J. Rawlings
Blood 2009; 114: 4034-4044.
[Abstract]
[Full text]
[PDF]
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy
- Barbara Cassani, Eugenio Montini, Giulietta Maruggi, Alessandro Ambrosi, Massimiliano Mirolo, Silvia Selleri, Erika Biral, Ilaria Frugnoli, Vivian Hernandez-Trujillo, Clelia Di Serio, Maria Grazia Roncarolo, Luigi Naldini, Fulvio Mavilio, and Alessandro Aiuti
Blood 2009; 114: 3546-3556.
[Abstract]
[Full text]
[PDF]
Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors
- Cecilia Frecha, Caroline Costa, Camille Lévy, Didier Nègre, Stephen J. Russell, Andrea Maisner, Gilles Salles, Kah-Whye Peng, Francois-Loïc Cosset, and Els Verhoeyen
Blood 2009; 114: 3173-3180.
[Abstract]
[Full text]
[PDF]
Lack of specific  -retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
- William R. Burns, Zhili Zheng, Steven A. Rosenberg, and Richard A. Morgan
Blood 2009; 114: 2888-2899.
[Abstract]
[Full text]
[PDF]
Restoration of NET formation by gene therapy in CGD controls aspergillosis
- Matteo Bianchi, Abdul Hakkim, Volker Brinkmann, Ulrich Siler, Reinhard A. Seger, Arturo Zychlinsky, and Janine Reichenbach
Blood 2009; 114: 2619-2622.
[Abstract]
[Full text]
[PDF]
AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
- Federico Mingozzi, Janneke J. Meulenberg, Daniel J. Hui, Etiena Basner-Tschakarjan, Nicole C. Hasbrouck, Shyrie A. Edmonson, Natalie A. Hutnick, Michael R. Betts, John J. Kastelein, Erik S. Stroes, and Katherine A. High
Blood 2009; 114: 2077-2086.
[Abstract]
[Full text]
[PDF]
Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)
- Ivan M. Borrello, Hyam I. Levitsky, Wendy Stock, Dorie Sher, Lu Qin, Daniel J. DeAngelo, Edwin P. Alyea, Richard M. Stone, Lloyd E. Damon, Charles A. Linker, Daniel J. Maslyar, and Kristen M. Hege
Blood 2009; 114: 1736-1745.
[Abstract]
[Full text]
[PDF]
Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells
- Thierry VandenDriessche, Zoltán Ivics, Zsuzsanna Izsvák, and Marinee K. L. Chuah
Blood 2009; 114: 1461-1468.
[Abstract]
[Full text]
[PDF]
Stable gene transfer and expression in cord blood–derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system
- Xingkui Xue, Xin Huang, Sonja E. Nodland, Lajos Mátés, Linan Ma, Zsuzsanna Izsvák, Zoltán Ivics, Tucker W. LeBien, R. Scott McIvor, John E. Wagner, and Xianzheng Zhou
Blood 2009; 114: 1319-1330.
[Abstract]
[Full text]
[PDF]
|
|
